|
GTF2H2B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.000000E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.296200E-03 |
| Normal-vs-Stage2 |
4.908800E-01 |
| Normal-vs-Stage3 |
1.221790E-03 |
| Normal-vs-Stage4 |
4.097700E-02 |
| Stage1-vs-Stage2 |
3.817000E-01 |
| Stage1-vs-Stage3 |
1.485380E-01 |
| Stage1-vs-Stage4 |
4.703800E-01 |
| Stage2-vs-Stage3 |
1.951830E-01 |
| Stage2-vs-Stage4 |
5.638600E-01 |
| Stage3-vs-Stage4 |
6.712300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.835900E-03 |
| Normal-vs-AfricanAmerican |
6.864000E-02 |
| Normal-vs-Asian |
2.609900E-02 |
| Caucasian-vs-AfricanAmerican |
6.491400E-01 |
| Caucasian-vs-Asian |
7.081200E-01 |
| AfricanAmerican-vs-Asian |
5.755000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.036000E-03 |
| Normal-vs-Female |
1.513970E-02 |
| Male-vs-Female |
7.153000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.785800E-04 |
| Normal-vs-Age(41-60Yrs) |
4.778100E-03 |
| Normal-vs-Age(61-80Yrs) |
2.163900E-02 |
| Normal-vs-Age(81-100Yrs) |
4.865700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.712400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.767570E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.882580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.763000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.063000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.072400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.375060E-03 |
| Normal-vs-Grade 2 |
1.695690E-02 |
| Normal-vs-Grade 3 |
1.815510E-02 |
| Normal-vs-Grade 4 |
1.216560E-03 |
| Grade 1-vs-Grade 2 |
1.145240E-01 |
| Grade 1-vs-Grade 3 |
7.191600E-02 |
| Grade 1-vs-Grade 4 |
6.576800E-01 |
| Grade 2-vs-Grade 3 |
9.192200E-01 |
| Grade 2-vs-Grade 4 |
1.455580E-01 |
| Grade 3-vs-Grade 4 |
5.875600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.520000E-03 |
| Normal-vs-ccB subtype |
1.660200E-03 |
| ccA subtype-vs-ccB subtype |
4.442000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.669900E-02 |
| Normal-vs-N1 |
1.68457999999427E-05 |
| N0-vs-N1 |
1.772000E-04 |
|
|
